Page 835 - ACCCN's Critical Care Nursing

812 I N D E X

classification of 458–460 H 2 RAs 516 sympathetic nervous system (SNS) 431, 432f,
mechanisms of 457–458 PPIs 516 788
nursing practice 461–462 sucralfate 516 heart failure and 228, 229f
collaborative management 462 protective mechanisms 515t renal system and 482
investigations and alignment 461–462 risk factors for 515 synapses 415–417, 417t, 418f
neuroprotection 462 stroke 462–463 synchronised intermittent mandatory ventilation
regeneration 462 acute, ED presentation and 594–596 (SIMV) 396, 397t, 788
resuscitation 461 aetiology of 462 systemic circulations 183f
pathophysiology of 460–461 cerebral venous thrombosis 464 systemic inflammatory response syndrome
posterior cord syndrome 460 collaborative management of 464 (SIRS) 551, 552t, 788
systemic effects of 461 haemorrhagic 463 progression of 566f
spinal meninges 429f ischaemic 463, 463t systemic vascular resistance (SVR) 202
spinal orthoses 635 fibrinolytic therapy in 595b pregnancy and 712
spinal precautions 635t SAH 463–464, 464t
spinal shock 461, 556–557 stroke volume (SV) 203
clinical manifestations of 556 pregnancy and 712 T
collaborative management for 556–557 structural abnormalities, cardiac surgery T wave 194, 194f
nursing practice in 556–557 for 291–293 tachyarrhythmias 252
respiratory muscle innervation by cord aortic valve disease 292–293 supraventricular, AV conduction during 255,
level 556t ischaemic heart disease 293 256f
spiritual wellness 171 mitral valve disease 293 tachycardia 190–191, 262–263, 263f
spleen injury 642–643 valvular disease 291–293, 292f atrial 255, 255f
spleen injury scale 643t structural defects 227 atrioventricular nodal reentry 257–258,
split-liver transplantation 523, 523f stupor 445 258f
spontaneous breathing trials (SBTs) 403 subarachnoid hemorrhage (SAH) 463–464, ICDs and, detection and classification
sputum analysis 336 464t of 283–284, 284f
sputum sample 344 submersion incident 788 multifocal atrial 255, 255f
ST elevation acute coronary syndrome substituted judgement principle 86 paroxysmal supraventricular 257
(STEACS) 218 sucralfate 516 polymorphic ventricular 263–264, 264f
ST elevation myocardial infarction (STEMI) sudden cardiac arrest (SCA) 788 reentry 257–258, 258f
218 aetiology of 654–655 sinus 252–253, 253f
St Jude Medical mechanical heart valve 295f causes of 655t supraventricular 254
ST segment 194, 194f chain of survival 656, 656f ventricular pulseless, ALS and 663, 665f
staffing 23–28 cooling techniques after 671, 671b, TAD see thoracic aortic dissection
critical care nursing 673b–674b TBI see traumatic brain injury
ACCCN position statement 24, 26 drowning and 669–670 TBSA see total body surface area assessment
WFCCN position statement 23–24 early recognition of 656–657, 656t TCD see transcranial Doppler ultrasound
education and training 27–28 electrical injuries and 669 Team Strategies and Tools to Enhance
expected standards 24, 25t fluid resuscitation during 666 Performance and Patient Safety
levels 24 incidence of 654–655 (TeamSTEPPS) 50
nurse-to-patient ratios 24, 25t maternal algorithm for 734b TeamSTEPPS see Team Strategies and Tools to
patient dependency 24–26 pacing 666 Enhance Performance and Patient
requirement calculation 27f pathophysiology of 655 Safety
roles 23–24 pregnancy and 669 technical practice development (tPD) 788
rostering 27 resuscitation systems and processes teeth cleaning 109
skill mix 26–27 655 TEG see thromboelastograph
surge plan development and 33 in-hospital survival 655 telehealth initiatives 49
STAI see State Trait Anxiety Inventory out-of-hospital survival 655 temporal cortex 418–419, 422f
Standard Precautions 118, 120 roles during 670 tenecteplase 221
standard transplant technique 311 ceasing CPR 671 tension pneumothorax 367
Starr-Edwards caged-ball valve 295f family presence during 670–671 terminal care, ICDs and 284
State Trait Anxiety Inventory (STAI) 61 postresuscitation phase 671 TGA see Therapeutic Goods Administration
status epilepticus (SE) 470–471 ultrasound imaging and 666–669 thalamus 788
clinical manifestations of 470 supplies, surge plan development and 33 Therapeutic Goods Administration (TGA)
nursing practice 470–471 supraventricular tachyarrhythmias, AV 95–96
collaborative practice 471 conduction during 255, 256f therapeutic intervention scoring system
post-SE assessment 471 supraventricular tachycardia (SVT) 254 (TISS) 26, 30–33, 31t
resuscitation 470–471 surfactant 326 thermodilution methods 203
pathophysiology of 470 surge plan development 33 third-degree atrioventricular block 261, 261f
statute law 80 critical care template 33–34 thoracic aortic dissection (TAD) 592–593
STEACS see ST elevation acute coronary space 33 thoracic expansion, assessment of 338f
syndrome staff 33 Thoratec USA VAD 310f
STEMI see ST elevation myocardial infarction supplies 33 thorax 326–328
steroid therapy 568–569 surgical technique (ST), tracheostomy procedure three-dimensional ECHO 206
for septic shock 554 using 386 thromboelastograph (TEG) 300
stethoscope 191t surrogate outcomes 40, 40t thrombolysis
stimulants, CNS, overdose of 600–601 surveillance, rates of nosocomial nursing care for 224
streptokinase 221 infections 119–120 nursing management after 221–223
stress 788 Surviving Sepsis campaign 551–552, 572b Thrombolysis in Myocardial Infarction (TIMI)
stress response actions, MODS and 566t SV see stroke volume flow grades, in coronary arteries
stress-related mucosal disease 513–516 SVG see saphenous vein graft 219–220, 221t
injury promoting factors to 515t SVR see systemic vascular resistance thrombolytic therapy 221–223
prevention of 515–516 SVT see supraventricular tachycardia thrombophylaxis 720
antacids 515–516 swine-origin influenza A virus 362 thrombotic microangiography 788
enteral nutrition 516 SWS see slow wave sleep tidal volume (V T ) 330, 392t, 393, 394t, 788